www.fdanews.com/articles/157608-fda-committee-to-review-copd-drug
FDA Committee to Review COPD Drug
August 2, 2013
On September 10, the FDA is set to discuss Theravance’s ANDA for Anoro Ellipta (umeclidinium bromide and vilanterol inhalation powder) for COPD and other pulmonary obstructions such as emphysema and bronchitis.
PharmaLive
PharmaLive